Legato Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$882K	Sell	39,007 -8,182	-17%	-$182K	0.08%	324
2025 Q4	$1.22M	Sell	47,189 -9,242	-16%	-$220K	0.11%	306
2025 Q3	$1.45M	Buy	56,431 +15,568	+38%	+$382K	0.16%	195
2025 Q2	$977K	Hold	40,863	–	–	0.12%	281
2025 Q1	$1.02M	Sell	40,863 -14,040	-26%	-$336K	0.14%	246
2024 Q4	$1.03M	Hold	54,903	–	–	0.14%	285
2024 Q3	$826K	Buy	54,903 +1,990	+4%	+$34K	0.1%	351
2024 Q2	$1.51M	Buy	52,913 +22,497	+74%	+$640K	0.2%	174
2024 Q1	$889K	Buy	30,416 +19,248	+172%	+$591K	0.11%	302
2023 Q4	$377K	Buy	11,168 +1,563	+16%	+$45.7K	0.05%	468
2023 Q3	$295K	Buy	+9,605	New	+$346K	0.04%	480